-20℃ 3 years powder
-80℃ 2 years in solvent
Hesperadin(IC50=250 nM) effectively inhibits Aurora B. It potently reduces the activity of AMPK, MAPKAP-K1, MKK1, Lck, CHK1 and PHK, but it could not inhibit MKK1 activity in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | 42.00 | |
5 mg | In stock | 59.00 | |
10 mg | In stock | 86.00 | |
25 mg | In stock | 143.00 | |
50 mg | In stock | 230.00 | |
100 mg | In stock | 410.00 | |
1 mL * 10 mM (in DMSO) | In stock | 66.00 |
Description | Hesperadin(IC50=250 nM) effectively inhibits Aurora B. It potently reduces the activity of AMPK, MAPKAP-K1, MKK1, Lck, CHK1 and PHK, but it could not inhibit MKK1 activity in vivo. |
Targets&IC50 | Aurora B (human) :ic50 250nM, TbAUK1 :ic50 40nM, |
Kinase Assay | For the Aurora B kinase assay, HeLa cells are lysed in a buffer containing 50 mM NaCl, then centrifuging at 13,000 rpm for 20 minutes at 4 °C. Discard supernatant, add 15 mL lysis buffer containing 250 mM NaCl in order to obtain active Aurora B kinase. Centrifuging at low-speed supernatant of the latter extract is used for immunoprecipitation. Monoclonal mouse anti–AIM-1, or mouse anti-HA, is coupled to GammaBind Plus Sepharose, and beads are rotated over-end in the extract for 90 minutes at 4 °C. Beads are washed, aliquoted, and washed in kinase buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 10 mM NaF). The kinase assay is performed with 10 μL beads in 20 μL kinase buffer containing 5 μg histone H3, 10 μM ATP, 2.5 μCi [γ-32P]ATP, and different concentrations of Hesperadin for 20 minutes at 37 °C. |
Cell Research |
HeLa cells and PtK1 cells are added Hesperadin 500 nM for 24 and 48 hours.
Cell lines: HeLa cells and PtK1 cells
|
Molecular Weight | 516.65 |
Formula | C29H32N4O3S |
CAS No. | 422513-13-1 |
-20℃ 3 years powder
-80℃ 2 years in solvent
DMSO: 55.3 mg/mL (100 mM)
Ethanol: 27.7 mg/mL (50 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
30% PEG400/0.5% Tween80/5% propylene glycol: 30 mg/mL
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.